Ministry of Health, Saudi Arabia — CureCurrent

Published trials9

Recruiting shown0

Roles2

SourceClinicalTrials.gov

Clinical trials

9 shown

SHIELD-T1D: Shingrix and GLP-1 Agonist for Beta-Cell Preservation in Recent-Onset Type 1 Diabetes.NCT07614412 · lead sponsor · 2027-01-01

NOT_YET_RECRUITING

Semaglutide GLP1 Agonists With Degludec Basal-bolus Insulin in Early Type 1 Diabetes to Basal-bolusNCT06057077 · lead sponsor · 2024-01-01

Targeting Metastatic Breast Cancers by Alkaline Glucosodiene Molecules Via a Metabolic Pathway Phase I Clinical TrialNCT05957939 · lead sponsor · 2024-01-01

The Study of Quadruple Therapy Quercetin, Zinc, Metformin, and EGCG as Adjuvant Therapy for Early, Metastatic Breast Cancer and Triple-negative Breast Cancer, a Novel MechanismNCT05680662 · lead sponsor · 2023-01-01

SGLT2 Inhibitors and Reducing the Risk of Cancers Among Diabetics , an Observational StudyNCT05612269 · lead sponsor · 2022-09-01

Suspicion of Hypoglycemic Effect of mRNA Based Covid-19 Vaccines (Polyethylene Glycol) Will Happen , Observational Study on Diabetic Patients at Saudia ArabiaNCT05087225 · lead sponsor · 2021-11-11

Efficacy and Safety of Modified ORS(Amr and Khulood ORS) in Diabetic Pilgrims During HajjNCT07618702 · collaborator · 2026-06-01

NOT_YET_RECRUITING

Investigating the Potential Role of a Novel Quadrate Combination Therapy Mifepristone(Antiprogestrone), Tamoxifen, Retinoic Acid and Cannabidiol ( Selective Cyp 26 Inhibitor) for Treating Early Breast Cancer.NCT05016349 · collaborator · 2021-08-01

The Effect of Daily Consumption of Extra Virgin Olive Oil on Blood Glucose Among Diabetic PatientsNCT03447301 · collaborator · 2018-02-25

Sponsor roles

lead sponsor6

collaborator3

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.